Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab

Exclusion Criteria

• •Participants who are pregnant or breast feeding at enrolment or wish to become pregnant in the next 24 weeks.
• •Participation in any Psoriasis-related clinical trial at the time of enrolment, at baseline or at any point during the study period.
• •Participants, who in the investigator's view, may not be able to accurately report their questionnaires